Lisa Elliott in

Lisa Elliott

Observer · DISC type ic
VP Global Asset and Product Strategy at LEO Pharma
📍 Copenhagen, Capital Region of Denmark, Denmark

Lisa Elliott is the VP of Global Asset and Payer Strategy at LEO Pharma, with over 15 years of experience in market access. Her expertise covers global pricing, HEOR, and RWE strategy across all phases of drug development. She holds a PhD from UNSW and a degree in Medical Science.

As interim EVP of Global Product Strategy, Lisa led a division of over 450 people, overseeing functions from Brand Teams and Medical Affairs to Commercial Analytics.

Read the full overview →
Experience
20 Years
Current Role
VP Global Asset and Product Strategy
Job Level
Senior
Location
Copenhagen, Capital Region of Denmark, Denmark
Personality Overview

How Lisa shows up

Curious
Example Seeker
Value Driven

They ask a lot of questions and rely heavily on information and collaterals. They can sound friendly and charming but can quickly change gears to become inquisitive and probing. They are generally good communicators and can be hard to convince.

Priorities

Topics Lisa cares about

Market Access Strategy
Her entire career and current role focuses on global market access, covering all phases of drug development from early-stage assets to established brands.
HEOR & RWE
She leads the Health Economics & Outcomes Research (HEOR) and Real-World Evidence (RWE) strategy, generation, and implementation at a global level.
+5 more topics Login to view topics
Career

Work history

2-2026
VP Global Asset and Product Strategy
LEO Pharma
5-2025 - 2-2026
EVP Global Product Strategy - interim
LEO Pharma
9-2024 - 2-2026
VP Global Asset and Payer Strategy
LEO Pharma
10-2022 - 9-2024
Vice President of Global Pricing, HEOR, Market Access and New Product Planning
LEO Pharma
2-2022 - 10-2022
Head of Global Strategic Pricing, HEOR&RWE and Market Access
LEO Pharma
In the press

Media appearances

To sharpen focus on the global commercialization of strategic products and the external partnership model, LEO Pharma makes changes to leadership. Featured in Ritzau
See now
2025 Management changes | LEO Pharma. Featured in LEO Pharma (official website)
+3 more appearances Login to view media
Education
2003 - 2005
PhD
UNSW
1999 - 2002
Medical science (Hons)
University of Technology Sydney
Social presence
in
Behavioral profile

DISC profile (public)

i

Influence (I)

Influence (I) reflects the degree to which a person prefers to work by influencing or persuading others. Those scoring high tend to be people oriented, motivated by social recognition and building relationships.

Other LEO Pharma Employees

Explore more public profiles from related professionals.

Lone Skytte
Lone Skytte
Senior Category Manager
LEO Pharma

More profiles

Discover additional public profiles from our index.

Michael Sobota
Michael Sobota
Customer Success Executive
ServiceNow
 Jayasimha Y.
Jayasimha Y.
Global Cyber Security Manager
PolyPeptide Group
 Michael Kosonog
Michael Kosonog
Partner | Deloitte Risk & Financial Advisory | Cyber Risk Services
 Julie Alfermann
Julie Alfermann
Managing Director, Global Sales Operations
Allison Transmission
Unlock the full playbookSee exactly how to sell to Lisa. Free, 10 seconds.